Announcements Trials
Browse Landscape

Status

Completed 4Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 110Observational 7

Sponsor

Cancer Type

Dermatologic 6Gynecologic 1

Conditions

Keratosis, Actinic 4Carcinoma, Basal Cell 2Uterine Cervical Dysplasia 1Keratosis 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Observational × Imiquimod × Clear all
NCT04809662 2024-11-07

Comparing Immune Responses to Topical Imiquimod

University of California, Davis

Terminated
6 enrolled
Dermatologic

Keratosis, Actinic

NCT06252857 2024-05-01

REDT-BCC

Maastricht University Medical Center

Unknown
142 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT05405270 2023-09-11

PRedICT-TOPIC

Catharina Ziekenhuis Eindhoven

Recruiting
410 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00189254 2022-02-07

A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ

Viatris Inc.

Completed
72 enrolled
Dermatologic

Keratosis, Actinic

NCT02362152 2019-12-13

RAPID-ACT

LEO Pharma

Completed
1,168 enrolled
Dermatologic

Keratosis, Actinic

NCT01212562 2011-09-02

IMCX

University of Ioannina

Completed
70 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT00114023 2007-02-19

1-Year Follow up to the 1473-IMIQ Study

Graceway Pharmaceuticals, LLC

Completed
84 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡